CFB

MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference

Retrieved on: 
목요일, 4월 18, 2024
Oral medicine, American Academy, Poster, Safety, Radiation, Month, PRO, CFB, Xerostomia, Conference, Treatment, Gene, Head, Parotid gland, Pharmaceutical industry

LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held from April 16-20, 2024, at the Hyatt Regency Grand Cypress in Orlando, FL.

Key Points: 
  • LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held from April 16-20, 2024, at the Hyatt Regency Grand Cypress in Orlando, FL.
  • We assessed the safety and efficacy of AAV2-hAQP1 gene therapy as a treatment for this condition.
  • Twenty-four participants with Grade 2/3 xerostomia at least five years after completing radiotherapy (2 years if HPV+) were enrolled in this multi-center, open-label, dose-escalation study.
  • The presentation will be available on the Posters and Publications page of the Company’s website after the respective presentation session has concluded.

CrossFirst Bankshares, Inc. Reports First Quarter 2024 Results

Retrieved on: 
월요일, 4월 15, 2024
Internet, CFB, Telephone, Webcast

LEAWOOD, Kan., April 15, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the first quarter ended March 31, 2024.

Key Points: 
  • LEAWOOD, Kan., April 15, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the first quarter ended March 31, 2024.
  • The first quarter earnings release can be viewed here: https://investors.crossfirstbankshares.com/financials/quarterly-reports
    CrossFirst Bankshares, Inc. will host a conference call to review first quarter results on Tuesday, April 16, 2024, at 10 a.m. CT / 11 a.m.
  • To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call.
  • To access the replay, dial (877) 344-7529 and enter the replay access code 1377131. International callers should dial +1 (412) 317-0088 and enter the same access code.

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease

Retrieved on: 
수요일, 4월 24, 2024
Science, Research, Pharmaceutical, Public Relations, Investor Relations, General Health, Health, Communications, Clinical Trials, Kidney disease, IgA nephropathy, RNA interference, Arrowhead, Kidney, CFB, RNA, Patient, Liver, System, Translational medicine, Discovery, MBA, Complement factor B, Vaccine

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial ( NCT06209177 ) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease.

Key Points: 
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial ( NCT06209177 ) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease.
  • James Hamilton, M.D., MBA, Chief of Discovery and Translational Medicine at Arrowhead, said: “In preclinical studies, ARO-CFB achieved deep and durable reductions in liver production of complement factor B, which is involved in alternative complement pathway activation and associated with pathogenesis of diseases involving complement activation.
  • ARO-CFB is our second clinical program designed to address diseases associated with activation of the complement pathway, the first being ARO-C3, our Phase 1 program targeting complement component 3.
  • ARO-CFB is being developed as a potential treatment for complement mediated kidney diseases such as immunoglobulin A nephropathy (IgAN), which is the most common glomerular disease worldwide and carries a high lifetime risk of progression to end-stage renal disease.

CrossFirst Bankshares, Inc. To Host First Quarter 2024 Earnings Call

Retrieved on: 
목요일, 3월 28, 2024
Telephone, Webcast, Internet, CFB, Cable television

LEAWOOD, Kan., March 28, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the parent company of CrossFirst Bank, announced today that management will host a conference call to review first quarter 2024 financial results on Tuesday, April 16, 2024, at 11:00 AM E.T.

Key Points: 
  • LEAWOOD, Kan., March 28, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the parent company of CrossFirst Bank, announced today that management will host a conference call to review first quarter 2024 financial results on Tuesday, April 16, 2024, at 11:00 AM E.T.
  • The call may also include discussion of company developments, forward-looking statements and other material information about business and financial matters.
  • The results are scheduled to be released after the market closes on Monday, April 15, 2024.
  • International callers should dial +1 (412) 317-1851 and request access to the CrossFirst Bankshares call.

Evolving Digital Innovation: Qubic's Journey Toward True AI

Retrieved on: 
목요일, 3월 28, 2024
ANN, Initial public offering, Brain, Intelligence, CFB, AI, ALGO, Strong AI, IPO, TPS, Computer, Heart, Miner, Cryptocurrency

Tallinn, Estonia, March 28, 2024 (GLOBE NEWSWIRE) -- Qubic embarks on a transformative journey to empower global innovation with the potential of True AI.

Key Points: 
  • Tallinn, Estonia, March 28, 2024 (GLOBE NEWSWIRE) -- Qubic embarks on a transformative journey to empower global innovation with the potential of True AI.
  • At the heart of Qubic's efforts is Aigarth, an advanced AI system that symbolizes the platform's goal to grant universal access to the most sophisticated AI capabilities available.
  • Aigarth analyzes data from AI miners to construct billions of neural networks, thereby mimicking the complexity of a human brain.
  • This remarkable capacity stands as a testament to Qubic's dedication to creating a high-performance computational AI network that acts as the foundational support for True AI development, providing swift, secure, and scalable solutions for AI integration.

Cleanroom Film & Bags Announces CFB CleanTronics Advanced Packaging for Semiconductors and Microelectronics

Retrieved on: 
화요일, 3월 26, 2024
Networks, Hardware, Electronic Design Automation, Consumer Electronics, Technology, Semiconductor, Packaging, Nanotechnology, Engineering, Chemicals, Plastics, Manufacturing, Telecommunications, ESD, IEST, Film, Electronics, CFB, Transport, Antistatic agent, NASA, Multimedia, ISO, Cleanroom, Silicon, Printed circuit board

Cleanroom Film and Bags (CFB), a division of C-P Flexible Packaging, has expanded its line of CFB CleanTronics Advanced Packaging for semiconductors, silicon wafers, microchips, printed circuit boards, motherboards, integrated circuits, microprocessors, fiber optics and other sensitive electronic components.

Key Points: 
  • Cleanroom Film and Bags (CFB), a division of C-P Flexible Packaging, has expanded its line of CFB CleanTronics Advanced Packaging for semiconductors, silicon wafers, microchips, printed circuit boards, motherboards, integrated circuits, microprocessors, fiber optics and other sensitive electronic components.
  • View the full release here: https://www.businesswire.com/news/home/20240326091962/en/
    CFB CleanTronics Advanced Packaging for semiconductors and microelectronics (Graphic: Business Wire)
    Having pioneered some of the first low outgassing films for electronics packaging, Cleanroom Film & Bags has over 35 years of experience paving the way in advanced packaging substrates and materials for semiconductors and microelectronics.
  • CFB CleanTronics Advanced Packaging can be manufactured to meet Level 50 or Level 100 IEST and NASA cleanliness specifications.
  • “Using exclusively American-made virgin resins and materials for CFB CleanTronics Advanced Packaging is one of the many ways we go above and beyond to provide unmatched quality.”
    To learn more about CFB CleanTronics Advanced Packaging, visit www.cleanroomfilm.com/electronic-packaging or contact [email protected] .

PGYTECH Astounds with the Global Release of the World's First Integrated CFexpress Card Storage and Reader Case

Retrieved on: 
수요일, 2월 28, 2024
SD card, Multimedia, CFB, CFA, CFexpress, IP54, Photography, SIM card, Tablet, Research, Video game

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- On February 28th, PGYTECH, the leading brand in photography accessories, officially introduced its latest product——CFexpress CreateMate Card Reader Case.

Key Points: 
  • NEW YORK, Feb. 28, 2024 /PRNewswire/ -- On February 28th, PGYTECH, the leading brand in photography accessories, officially introduced its latest product——CFexpress CreateMate Card Reader Case.
  • Type A/SD and Type B/SD versions (hereafter referred to as CFA/CFB Card Reader Case).
  • This groundbreaking product is the world's first integrated card reader case designed exclusively for CFexpress cards, combining convenient storage and ultra-high-speed reading functions, aiming to be the efficient creative companion for professional photographers.
  • As a milestone product under PGYTECH, the first-generation SD version of the memory card reader case, launched in June last year, received fervent acclaim from the industry and photography enthusiasts.

Valmet to add biomass co-firing to a coal-fired circulating fluidized bed boiler for PT. Cikarang Listrindo in Indonesia

Retrieved on: 
수요일, 2월 21, 2024
Paper, Engineering, Nasdaq Helsinki, Coal, CFB, IPP, Independent power producer, Biomass, Osakeyhtiö, Senior, EET, CO2, Biofuel, Automation, Electricity, Renewable energy

ESPOO, Finland, Feb. 21, 2024 /PRNewswire/ -- Valmet will supply a partial bioconversion for PT. Cikarang Listrindo Tbk's coal-fired circulating fluidized bed (CFB) boiler in Babelan, Indonesia. The investment reflects Cikarang Listrindo's initiative for greener energy production and environmentally friendlier operation by reducing reliance on fossil fuels and cutting CO2 emissions.

Key Points: 
  • Cikarang Listrindo Tbk's coal-fired circulating fluidized bed (CFB) boiler in Babelan, Indonesia.
  • Cikarang Listrindo is also utilizing renewable fuels in its steam generation process by rebuilding the existing CFB boiler in unit 2.
  • Cikarang Listrindo Tbk, located in Bekasi Regency, Indonesia, is the longest operating Independent Power Producer (IPP) in Indonesia.
  • Cikarang Listrindo started its initial operation in 1993 and is currently serving more than 2,600 industrial customers in five industrial estates in Cikarang.

CrossFirst Bankshares, Inc. Reports Fourth Quarter and Record Full-Year 2023 Results

Retrieved on: 
월요일, 1월 22, 2024
Telephone, Internet, CFB, Webcast

LEAWOOD, Kan., Jan. 22, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the fourth quarter and full-year ended December 31, 2023.

Key Points: 
  • LEAWOOD, Kan., Jan. 22, 2024 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the fourth quarter and full-year ended December 31, 2023.
  • The fourth quarter and full-year earnings release can be viewed here: https://investors.crossfirstbankshares.com/financials/quarterly-reports
    CrossFirst Bankshares, Inc. will host a conference call to review fourth quarter and full-year results on Tuesday, January 23, 2024, at 10 a.m. CT / 11 a.m.
  • To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call.
  • The event will also be broadcast live over the internet and can be accessed via the following link: https://edge.media-server.com/mmc/p/6qo9vh8p .

CrossFirst Bankshares, Inc. Announces Bond Portfolio Repositioning

Retrieved on: 
화요일, 12월 19, 2023
CFB, Sale, Security (finance)

LEAWOOD, Kan., Dec. 19, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: CFB) -- CrossFirst Bankshares, Inc. (the “Company”), the bank holding company for CrossFirst Bank (the “Bank”) announced the sale of approximately $80 million of available-for-sale municipal securities, resulting in an after-tax loss of approximately $0.8 million.

Key Points: 
  • LEAWOOD, Kan., Dec. 19, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: CFB) -- CrossFirst Bankshares, Inc. (the “Company”), the bank holding company for CrossFirst Bank (the “Bank”) announced the sale of approximately $80 million of available-for-sale municipal securities, resulting in an after-tax loss of approximately $0.8 million.
  • Proceeds from the sale will be deployed into higher-yielding agency mortgage-backed products, as well as used to pay off existing wholesale borrowings.
  • The Company expects the transaction will contribute additional diluted earnings per share accretion of $0.02 in 2024 representing less than a 1-year earn-back.
  • The loss on the sale of securities is expected to have a neutral impact on consolidated shareholders’ equity and the Company’s book value per share.